Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Change in Receivables (2022 - 2025)

OneMedNet has reported Change in Receivables over the past 4 years, most recently at -$87000.0 for Q4 2025.

  • Quarterly Change in Receivables fell 158.0% to -$87000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $282000.0 through Dec 2025, up 362.3% year-over-year, with the annual reading at $282000.0 for FY2025, 362.3% up from the prior year.
  • Change in Receivables was -$87000.0 for Q4 2025 at OneMedNet, down from $328000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $328000.0 in Q3 2025 and troughed at -$178000.0 in Q2 2024.
  • The 4-year median for Change in Receivables is $7000.0 (2025), against an average of $24181.2.
  • The largest YoY upside for Change in Receivables was 2833.33% in 2025 against a maximum downside of 158.0% in 2025.
  • A 4-year view of Change in Receivables shows it stood at -$161645.0 in 2022, then skyrocketed by 129.08% to $47000.0 in 2023, then surged by 219.15% to $150000.0 in 2024, then plummeted by 158.0% to -$87000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Change in Receivables are -$87000.0 (Q4 2025), $328000.0 (Q3 2025), and $7000.0 (Q2 2025).